Alternative to NAD+ IV Therapy
NAD+ IV drips are expensive, clinic-bound and time-consuming. For researchers interested in the same cellular-energy pathways, two routes attract attention: NAD+ / NMN as research compounds, and MOTS-c, a mitochondrial-derived signalling peptide. Both are studied for the metabolic machinery an IV drip is trying to reach — without the drip chair.
NAD+ IV therapy has become a fixture of longevity clinics, but the format is demanding: hours hooked to a drip, a premium price per session, and a schedule built around appointments. The underlying interest is cellular energy — NAD+ is a coenzyme central to mitochondrial function and sirtuin activity, both of which decline with age. Researchers exploring that biology without the clinic look at NAD+ and its precursor NMN directly, and at MOTS-c, a peptide encoded within mitochondrial DNA and studied as an exercise-mimetic and metabolic regulator. None of these is a therapy or a medicine; they are supplied strictly for research purposes only.
SIDE BY SIDE
| NAD+ IV drip | Research approach | |
|---|---|---|
| Format | Clinic infusion — hours per session, by appointment | Lyophilised research compounds studied in the lab |
| Primary target | Raising the NAD+ coenzyme pool acutely | NAD+/NMN (coenzyme pool) and MOTS-c (mitochondrial signalling) |
| Mechanism studied | Energy metabolism, sirtuin activity, DNA repair | Same NAD+ biology, plus AMPK / metabolic regulation via MOTS-c |
| Cost profile | Premium per-session clinic pricing | Per-vial research pricing, no clinic time |
| Availability here | n/a | MOTS-c in stock; NAD+/NMN arriving soon — register interest |
| Regulatory status here | Clinical service | Research compounds — for research purposes only |
WHAT TO RESEARCH INSTEAD
MOTS-c
A mitochondrial-derived peptide studied for metabolic regulation, AMPK activation and exercise-mimetic effects.
R399View product →
NAD+ / NMN
The coenzyme central to cellular energy and sirtuin activity — arriving shortly.
NAD+ — register interest →
Longevity research range
The wider cellular-ageing and healthspan research collection.
Explore longevity compounds →
WHEN TO RESEARCH WHICH
If the research interest is the NAD+ coenzyme pool itself, NAD+ and its precursor NMN are the direct targets — arriving shortly; register interest. If the interest is upstream mitochondrial signalling — AMPK activation, metabolic regulation, exercise-mimetic effects — MOTS-c is the most-studied mitochondrial-derived peptide and is in stock now. An IV drip is a delivery format, not a distinct mechanism; the compounds are the actual variables under study. For research purposes only.
FREQUENTLY ASKED
Is there an alternative to NAD+ IV therapy?
Researchers interested in the same cellular-energy biology study NAD+ and its precursor NMN directly, and MOTS-c, a mitochondrial-derived signalling peptide. These are research compounds supplied strictly for research purposes only — not a therapy or a substitute for medical care.
What is MOTS-c studied for?
MOTS-c is a peptide encoded within mitochondrial DNA, studied for metabolic regulation, AMPK activation and exercise-mimetic effects. It is HPLC-verified and CoA-certified, and supplied for research purposes only.
Do you stock NAD+?
MOTS-c is in stock now. NAD+ and NMN are arriving shortly — register interest via our NAD+ page and we will notify you the moment they land. All compounds are for research purposes only.
MORE ALTERNATIVES
All products supplied for research purposes only. Not for human consumption. Nothing here is medical advice or a substitute for a qualified clinician.